Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the online publication of ...

Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for breast cancer therapeutics.

CNS metastases in EGFR-mutant NSCLC are prevalent and worsen prognosis, especially with acquired progression during treatment. Amivantamab plus lazertinib shows promising CNS activity, but current ...

A new study from researchers at The University of Texas MD Anderson Cancer Center shows that the glucose-fructose mix found in sugary drinks directly fuels metastasis in preclinical models of advanced ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow growth and treatment side e ...

Results from the phase 3 TROPION-Breast02 trial, presented at the ESMO 2025, show that Datroway® (datopotamab deruxtecan) significantly extended overall survival by five months versus chemotherapy in ...

While at 3 months fewer patients in supervised physical activity arm reported visual analog scale loss of energy (45% vs 62%) ...

Northwestern Medicine announced Tuesday that for the first time, its doctors have successfully treated metastatic eye cancer using a method that delivers chemotherapy directly to the liver. The ...

Xtandi addition to ADT and radiation did not significantly improve MFS in the overall high-risk prostate cancer population. Patients with clinical N1 disease showed improved five-year MFS with Xtandi, ...